BridgeBio Pharma, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -43.83M-184.20M-288.58M-505.49M-586.48M-485.08M-653.25M-543.35M
Depreciation and Depletion 4.10M4.10M3.70M
Share-based Compensation 1.84M6.07M21.37M58.46M105.57M93.83M115.02M113.87M
Gains from Sales and Divestitures 1.12M2.36M1.57M1.95M3.61M3.81M
Gains from Investment Securities -0.26M-0.25M3.55M6.76M-7.09M-2.17M6.88M7.53M
Asset Writedowns and Impairment 12.72M0.27M
Non-cash Items 0.51M1.74M5.03M7.09M178.59M10.27M
Cash from Operations -40.49M-136.64M-253.59M-399.71M-497.93M-419.49M-527.72M-520.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.78M1.51M17.74M5.79M8.57M8.91M15.76M
Depreciation & Amortization (CF) 0.86M1.46M5.84M6.77M6.49M6.08M
Change in Working Capital
Change in Receivables -15.17M-15.33M2.97M
Change in Account Payables 1.58M16.70M-4.66M-0.73M2.83M-0.35M2.78M1.51M
Change in Accured Expenses 1.13M3.40M9.27M8.59M14.16M-7.73M7.80M16.99M
Other Working Capital Changes 4.30M6.10M16.93M7.06M9.82M15.26M-5.44M21.88M
Investing Activities
Capital Expenditures 0.46M2.18M2.64M7.52M13.25M4.82M1.31M0.93M
Sales of Property, Plant and Equipment 10.00M
Change in Intangibles 35.00M1.50M7.97M
Acquisitions 0.78M
Divestments 34.15M25.68M
Change in Acquisitions & Divestments 249.14M380.20M479.69M110.56M95.00M
Cash from Investing Activities -0.46M-21.04M-217.25M-52.99M-200.83M453.15M54.03M60.78M
Financing Activities
Other financing activities 0.54M0.00M23.93M24.09M16.06M0.84M15.99M
Cash from Financing Activities 112.98M501.55M398.79M447.19M736.45M-13.13M451.54M748.46M
Dividend Payments
Dividends Paid - Common 1.15M44.23M55.01M5.00M
Additional items
Change in Cash 72.03M343.87M-72.05M-5.52M37.69M20.52M-22.15M288.51M
Free Cash Flow -40.95M-138.82M-256.23M-407.23M-511.18M-424.31M-529.03M-521.66M
Net Cash Flow 72.03M343.87M-72.05M-5.52M37.69M20.52M-22.15M288.51M